FDA Inspection 1169371 — American Red Cross Blood Services
The FDA completed an inspection of American Red Cross Blood Services on May 5, 2022 in Birmingham, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 5, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Birmingham, AL (United States)